dean s symposium the role of pharmaceuticals in public
play

Deans Symposium: The Role Of Pharmaceuticals in Public Health - PowerPoint PPT Presentation

Jun 06, 2023 •33 likes •73 views

Deans Symposium: The Role Of Pharmaceuticals in Public Health Universal Access and Price and Availability: Ensuring Access to Life-Saving Medicines Globally Margaret Ewen Health Action International, Amsterdam September 15, 2016 Public

  2. Dean’s Symposium: The Role Of Pharmaceuticals in Public Health Universal Access and Price and Availability: Ensuring Access to Life-Saving Medicines Globally Margaret Ewen Health Action International, Amsterdam September 15, 2016

  3. Public advertisement, Guatemala, 2006 and 2010 "I have diabetes. If my medication fails, I could suffer a diabetic coma." "I don't take chances. I only use originals" 3

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

Markets, Development Assistance, and Access to Medicines: Enabling and Informing Policy Deans

Markets, Development Assistance, and Access to Medicines: Enabling and Informing Policy Deans

Markets, Development Assistance, and Access to Medicines: Enabling and Informing Policy Deans Symposium The Role of Pharmaceuticals in Public Health Boston University School of Public Health September 15, 2016 Olusoji Adeyi, MD, MBA, DrPH

492 views • 20 slides
Health Reform in China, Universal Health Coverage, and Access to Medicines Ye Lu Ph.D, Professor

Health Reform in China, Universal Health Coverage, and Access to Medicines Ye Lu Ph.D, Professor

Health Reform in China, Universal Health Coverage, and Access to Medicines Ye Lu Ph.D, Professor School of Public Health, Fudan University lye@fudan.edu.cn Deans Symposium The Role of Pharmaceuticals in Public Health Boston University

423 views • 13 slides
The Role of Nursing During Public Health Emergencies & Opportunities for the Future Kristin

The Role of Nursing During Public Health Emergencies & Opportunities for the Future Kristin

The Role of Nursing During Public Health Emergencies & Opportunities for the Future Kristin ine Q Qures eshi, i, P PhD, R RN, F FAAN, CEN CEN, P PHNA-BC BC Profes essor a and Associate D e Dean f for R Resea earch a and G

154 views • 12 slides
Pharmaceuticals in Soil, Sludge and Slurry Pharmaceuticals in Soil, Sludge and Slurry Nicole

Pharmaceuticals in Soil, Sludge and Slurry Pharmaceuticals in Soil, Sludge and Slurry Nicole

Pharmaceuticals in Soil, Sludge and Slurry Pharmaceuticals in Soil, Sludge and Slurry Nicole Adler, Christoph Schlter, Ines Vogel & Unit IV 2.2 - Pharmaceuticals, Washing and cleansing agents Federal Environment Agency of Germany

366 views • 18 slides
MGC Pharmaceuticals November 2015 Company Overview MGC Pharmaceuticals (MGC) , is a medical and

MGC Pharmaceuticals November 2015 Company Overview MGC Pharmaceuticals (MGC) , is a medical and

MGC Pharmaceuticals November 2015 Company Overview MGC Pharmaceuticals (MGC) , is a medical and cosmetic cannabis company with licenses to grow, extract and sell Cannabis Sativa in Slovenia, inside MGC Pharmaceuticals the EU. Capitalising on

473 views • 13 slides
Introduction to Part 266 Subpart P OUTLINE 1. Goals of the Pharmaceuticals Rule 2. Effective

Introduction to Part 266 Subpart P OUTLINE 1. Goals of the Pharmaceuticals Rule 2. Effective

HAZARDOUS WASTE PHARMACEUTICALS & AMENDMENT TO THE NICOTINE LISTING (P075) FINAL RULE PUBLIC WEBINARS PRESENTED BY EPA FEBRUARY & MARCH 2019 Introduction to Part 266 Subpart P OUTLINE 1. Goals of the Pharmaceuticals Rule 2. Effective

1.33k views • 76 slides
Introduction to Part 266 Subpart P OUTLINE 1. Goals of the Pharmaceuticals Rule 2. Effective

Introduction to Part 266 Subpart P OUTLINE 1. Goals of the Pharmaceuticals Rule 2. Effective

HAZARDOUS WASTE PHARMACEUTICALS & AMENDMENT TO THE NICOTINE LISTING (P075) FINAL RULE PUBLIC WEBINARS PRESENTED BY EPA FEBRUARY & MARCH 2019 Introduction to Part 266 Subpart P OUTLINE 1. Goals of the Pharmaceuticals Rule 2. Effective

986 views • 77 slides
Introduction to Part 266 Subpart P OUTLINE 1. Goals & Overview of the Pharmaceuticals Final

Introduction to Part 266 Subpart P OUTLINE 1. Goals & Overview of the Pharmaceuticals Final

HAZARDOUS WASTE PHARMACEUTICALS & AMENDMENT TO THE NICOTINE LISTING (P075) FINAL RULE PUBLIC WEBINAR PRESENTED BY EPA APRIL 2019 Introduction to Part 266 Subpart P OUTLINE 1. Goals & Overview of the Pharmaceuticals Final Rule 2.

1.42k views • 76 slides
An Introduction to XHTM L Print Presented to the W 3C Print Symposium 2006 Dean Anderson,

An Introduction to XHTM L Print Presented to the W 3C Print Symposium 2006 Dean Anderson,

An Introduction to XHTM L Print Presented to the W 3C Print Symposium 2006 Dean Anderson, Hewlett-Packard Company October 17, 2006 dean.anderson@ hp.com XHTML -Print So why does the world need another print language? W e already have:

428 views • 29 slides
FAO Symposium on FAO Symposium on The role of agricultural biotechnologies for production of

FAO Symposium on FAO Symposium on The role of agricultural biotechnologies for production of

FAO Symposium on FAO Symposium on The role of agricultural biotechnologies for production of bio The role of agricultural biotechnologies for production of bio- -energy in energy in developing countries" developing

457 views • 42 slides
The Role and Future of Schools of Education Dr. Michael E. Spagna Dean Michael D. Eisner

The Role and Future of Schools of Education Dr. Michael E. Spagna Dean Michael D. Eisner

The Role and Future of Schools of Education Dr. Michael E. Spagna Dean Michael D. Eisner College of Education November 19, 2013 Responsive to Community Needs (Stewards of Place) Prepare High Quality Teachers, Administrators,

330 views • 21 slides
Advancing the College of Engineering and Science: The Role of the Associate Dean for Research and

Advancing the College of Engineering and Science: The Role of the Associate Dean for Research and

Advancing the College of Engineering and Science: The Role of the Associate Dean for Research and Graduate Studies Professor Daniel L. Noneaker Associate Chair & Graduate Program Coordinator Holcombe Department of Electrical and Computer

478 views • 18 slides
Fentanyl, Fentanyl Analogs, Carfentanil, Counterfeit Pharmaceuticals & Other Dangerous

Fentanyl, Fentanyl Analogs, Carfentanil, Counterfeit Pharmaceuticals & Other Dangerous

Fentanyl, Fentanyl Analogs, Carfentanil, Counterfeit Pharmaceuticals & Other Dangerous Substances What you do not know can kill you! DEADLY! Center for Public Safety Innovation 1 Lieutenant Dan Zsido, Retired Pinellas County Sheriffs

977 views • 70 slides
Public integrity reform: Public integrity reform: The role of the Ombudsman The role of the

Public integrity reform: Public integrity reform: The role of the Ombudsman The role of the

Public integrity reform: Public integrity reform: The role of the Ombudsman The role of the Ombudsman Richar chard B d Bingham ngham SA Ombudsman 19 September 2013 1 What I will speak about What I will speak about compare and contrast

449 views • 18 slides
INTERNATIONAL SYMPOSIUM On THE CHANGING ROLE OF PARLIAMENT IN THE BUDGET PROCESS 8-9 October

INTERNATIONAL SYMPOSIUM On THE CHANGING ROLE OF PARLIAMENT IN THE BUDGET PROCESS 8-9 October

INTERNATIONAL SYMPOSIUM On THE CHANGING ROLE OF PARLIAMENT IN THE BUDGET PROCESS 8-9 October 2008 Korel Thermal Hotel, Afyonkarahisar, Turkey Session Three Accountability of Government and Financial Transparency Scrutiny and monitoring

501 views • 14 slides
SESSION III: THE SPECIALTY PHARMACEUTICALS MARKETPLACE: IS PRICE INELASTICITY SUSTAINABLE?

SESSION III: THE SPECIALTY PHARMACEUTICALS MARKETPLACE: IS PRICE INELASTICITY SUSTAINABLE?

SESSION III: THE SPECIALTY PHARMACEUTICALS MARKETPLACE: IS PRICE INELASTICITY SUSTAINABLE? Headlines Exclusive Costs to public of $84,000 hp C Drug outreageous- Kaiser.

214 views • 10 slides
Hospital Accountability Planning Submission 2014-2015 Education Session January 14, 2014 Agenda

Hospital Accountability Planning Submission 2014-2015 Education Session January 14, 2014 Agenda

Hospital Accountability Planning Submission 2014-2015 Education Session January 14, 2014 Agenda 1. Context 2. Alignment 3. HSAA Organization 4. Structure 5. Guiding Principles 6. HSAA Schedules Naming Convention 7. Summary of

595 views • 43 slides
Healthcare changes across Barnet, Enfield and Haringey Purpose: To provide an update on the

Healthcare changes across Barnet, Enfield and Haringey Purpose: To provide an update on the

Healthcare changes across Barnet, Enfield and Haringey Purpose: To provide an update on the changes that will be implemented across Barnet, Enfield and Haringey from autumn 2013 Audience: Barnet HWB Date: 4 October 2012 BEH Clinical

152 views • 12 slides
Q3FY18 RESULTS Results Summary Operating Highlights Financial Summary Key Strategies Appendix

Q3FY18 RESULTS Results Summary Operating Highlights Financial Summary Key Strategies Appendix

FINOLEX INDUSTRIES LIMITED Q3FY18 RESULTS Results Summary Operating Highlights Financial Summary Key Strategies Appendix Q3FY18 Results Summary 50.2 % 26.5% 50.2 % 61,514 71,107 Pipes and 56,226 40,966 Fittings volume Q3FY17 Q3FY18

554 views • 23 slides
LRCT RCTC C SERVI VICE E PRO ROVI VIDER DER & T & TRAIN AINING G OFFIC ICERS

LRCT RCTC C SERVI VICE E PRO ROVI VIDER DER & T & TRAIN AINING G OFFIC ICERS

LRCT RCTC C SERVI VICE E PRO ROVI VIDER DER & T & TRAIN AINING G OFFIC ICERS ERS AS ASSESSO SSORS RS USER GRO ROUP UP - 8 TH TH SEPTEMB EMBER ER 2011 11 Mark rk Smith th Chairm rman n NHS London n Servi vice

726 views • 38 slides
INSULIN INITIATION IN TYPE 2 DIABETES A/Prof Mark Savage: Endocrinologist Dr Jessica Triay:

INSULIN INITIATION IN TYPE 2 DIABETES A/Prof Mark Savage: Endocrinologist Dr Jessica Triay:

INSULIN INITIATION IN TYPE 2 DIABETES A/Prof Mark Savage: Endocrinologist Dr Jessica Triay: Endocrinologist Dr Jessica Disler: Endocrinology advanced trainee Karen Gray: Credentialled diabetes eduactor Topics to be covered Identifying the

819 views • 80 slides
THE RIGHT TIME: Results of the SMART Pilot Program A BC Womens Hospital + Health Centre

THE RIGHT TIME: Results of the SMART Pilot Program A BC Womens Hospital + Health Centre

SAFE METHODS AT THE RIGHT TIME: Results of the SMART Pilot Program A BC Womens Hospital + Health Centre partnership with BC health authorities and abortion providers Presented by Dr. Sheila With and Suzie Maginley ACKNOWLEDGMENTS Thank you

498 views • 13 slides
Reducing Health Disparities Jeffrey F. Peipert, M.D., Ph.D. Vice Chair of Clinical Research

Reducing Health Disparities Jeffrey F. Peipert, M.D., Ph.D. Vice Chair of Clinical Research

The Contraceptive CHOICE Project: Importance of Long-Acting Reversible Contraception in Reducing Health Disparities Jeffrey F. Peipert, M.D., Ph.D. Vice Chair of Clinical Research Robert J. Terry Professor Department of Obstetrics &

574 views • 44 slides
Making Factors when Considering the Use of the Contraceptive Implant Joseph Guillory El Centro

Making Factors when Considering the Use of the Contraceptive Implant Joseph Guillory El Centro

Identification of Female Patient Decision- Making Factors when Considering the Use of the Contraceptive Implant Joseph Guillory El Centro de Corazon Houston, Texas Introduction National Unplanned Pregnancy Crisis Nexplanon/Implanon

272 views • 11 slides

More recommend